# Interrupters of VAscular daMAge in Malignant Hypertension

> **NCT04991077** · — · COMPLETED · sponsor: **Centre Hospitalier de PAU** · enrollment: 45 (actual)

## Conditions studied

- Malignant Hypertension

## Interventions

- **BIOLOGICAL:** analyse of angiogenic, vasoactive and VEGF systems

## Key facts

- **NCT ID:** NCT04991077
- **Lead sponsor:** Centre Hospitalier de PAU
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-07
- **Primary completion:** 2024-10-11
- **Final completion:** 2024-10-11
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04991077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04991077, "Interrupters of VAscular daMAge in Malignant Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04991077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*